MiNK Therapeutics, Inc. (INKT)

MiNK Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.28	4.58	3.37	19.64	38.89	2.69
Cash & Short-Term Investments	14.28	4.58	3.37	19.64	38.89	2.69
Cash Growth	125.67%	35.93%	-82.85%	-49.51%	1345.06%	799.94%
Other Receivables	-	-	-	-	-	0.25
Receivables	-	-	-	-	-	0.25
Prepaid Expenses	0.25	0.25	0.05	0.3	0	0.49
Other Current Assets	0	0.16	0.18	0.47	0.74	0.66
Total Current Assets	14.53	4.99	3.6	20.4	39.63	4.1
Property, Plant & Equipment	0.43	0.73	0.95	1.07	0.61	0.46
Total Assets	14.96	5.72	4.55	21.47	40.24	4.56
Accounts Payable	3.69	2.73	3.91	5.82	3	3.14
Accrued Expenses	1.26	1.87	5.04	4.24	1.76	1.86
Other Current Liabilities	2.76	2.36	2.45	2.62	11.71	9.22
Total Current Liabilities	13.43	6.96	11.4	12.68	16.47	14.22
Long-Term Debt	-	4.92	-	-	-	43.82
Other Long-Term Liabilities	15.04	13.42	11.21	9.19	-	0.38
Total Liabilities	28.48	25.31	22.61	21.87	16.47	58.43
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	141.25	125.23	115.77	110.83	107.35	0.38
Retained Earnings	-154.07	-144.18	-133.4	-110.94	-82.95	-52.74
Comprehensive Income & Other	-0.69	-0.63	-0.43	-0.29	-0.63	-1.52
Shareholders' Equity	-13.51	-19.59	-18.06	-0.4	23.78	-53.87
Total Liabilities & Equity	14.96	5.72	4.55	21.47	40.24	4.56
Total Debt	5.73	4.92	-	-	-	43.82
Net Cash (Debt)	8.56	-0.35	3.37	19.64	38.89	-41.13
Net Cash Growth	398.43%	-	-82.85%	-49.51%	-	-
Net Cash Per Share	2.09	-0.09	0.98	5.83	14.94	-17.06
Filing Date Shares Outstanding	4.69	3.97	3.47	3.39	3.36	2.42
Total Common Shares Outstanding	4.6	3.96	3.46	3.39	3.35	2.42
Working Capital	1.1	-1.97	-7.8	7.72	23.17	-10.13
Book Value Per Share	-2.94	-4.94	-5.22	-0.12	7.10	-22.28
Tangible Book Value	-13.51	-19.59	-18.06	-0.4	23.78	-53.87
Tangible Book Value Per Share	-2.94	-4.94	-5.22	-0.12	7.10	-22.28
Machinery	1	1.26	1.45	1.35	0.78	0.56

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q